# Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris

> **NCT02525822** · PHASE2 · UNKNOWN · sponsor: **Valeant Pharmaceuticals** · enrollment: 210 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** IDP-123 Lotion
- **DRUG:** Tazorac Cream, 0.1%,
- **DRUG:** Vehicle Cream
- **DRUG:** Vehicle Lotion

## Key facts

- **NCT ID:** NCT02525822
- **Lead sponsor:** Valeant Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2015-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02525822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02525822, "Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02525822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*